Skip to main content

Advertisement

SpringerLink
Log in

Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC)

  • NON-THEMATIC REVIEW
  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

The authors compared N0 with N+ cases in neoadjuvant chemotherapy regression and recurrence. During a 12-year period, 180 consecutive oral squamous cell cancer patients were observed. Of these patients, 78 were N0 and 102 N+ stages. The drugs used were as follows: bleomycin, vincristine, methotrexate, and mitolactol. After three courses of chemotherapy, the regression (complete response (CR), partial response (PR), and no response (NR)) and side effect rate were determined. All patients were operated on and observed for the number and localization of recurrences during 3 year follow-up time. The N0 cases came from T2–3, while N+ was from T2–4a (AJCC 2002). The regression in the N0 group was CR 46%, PR 53%, and NR 1%; but in the N+ group, it was CR 12%, PR 72%, and NR 16%. The regression rate was significantly higher (p = 0.00025) for N0 group than N+ group. The regression rate for T3 N0 was significantly higher (p = 0.055) than for T3 N+ cases. In the N0 stage, the regression rate was significantly higher (p = 0.0174) for T2 than T3. In N+ stage, there was no significant difference (p = 0.183) for T2–4a. The side effects were slight. The recurrence rate for the N0 group was significantly lower (15%, p = 0.000069), while for N+ group, it was 59%. The dependence in the T3 cases was also significant (p = 0.009) in the 3-year tumor-free survival. The N stage seems a more important prognostic factor for chemotherapy response and recurrence rate than the T stage. Stage III can be divided into subgroups without metastasis (III.a) and with metastasis (III.b.), based on significant difference in regression and recurrence rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gaudi, I., & Kásler, M. (2002). The course of cancer mortality in Hungary between 1975–2001 (English abstract). Magyar Onkologia, 46, 291–295.

    PubMed  Google Scholar 

  2. Németh, Zs, Velich, N., Bogdán, S., Ujpál, M., Szabó, G., & Suba, Z. S. (2005). The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors. Neoplasma, 52, 95–101.

    PubMed  Google Scholar 

  3. Bettendorf, O., Piffko, J., & Bankfalvi, A. (2004). Prognostic and predictive factors in oral squamous cell cancer: Important tools for planning individual therapy? Oral Oncology, 40, 110–119.

    Article  CAS  PubMed  Google Scholar 

  4. Taylor, S. G. (1997). Head and neck cancer. Cancer Chemother Biol Response Modif, 17, 428–443

    Google Scholar 

  5. Giralt, J. L., Gonzalez, J., Campo, J. M., Maldonado, J., Sanz, X., Pamias, J., et al. (2000). Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer, 89, 939–945.

    Article  CAS  PubMed  Google Scholar 

  6. Gibson, M. K., & Forastiere, A. A. (2004). Multidisciplinary approaches in the management of advanced head and necks: State of art. Current Opinion in Oncology, 16, 220–224.

    Article  PubMed  Google Scholar 

  7. Forastiere, A. A., & Trotti, A. (1999). Radiotherapy and concurrent chemotherapy: A strategy that improves locoregional control and survival in oropharyngeal cancer. Journal of the National Cancer Institute, 91, 20056–22066.

    Google Scholar 

  8. Gibson, M. K., & Forastiere, A. A. (2006). Reassesment of the role of induction chemotherapy for head and neck cancer. The Lancet Oncology, 7, 565–574.

    Article  PubMed  Google Scholar 

  9. Bryne, M., Koppang, H. S., Lilleng, R., & Kjaerheim, A. (1992). Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. The Journal of Pathology, 166, 375–381.

    Article  CAS  PubMed  Google Scholar 

  10. Spiro, R. H., Guillamondegui, O., Paulin, A. F., & Huvos, A. G. (1999). Pattern of invasion and margin assessment in patients with oral tongue cancer. Head & Neck, 21, 408–413.

    Article  CAS  Google Scholar 

  11. Psyrri, A., Kwong, M., DiStasio, S., Lekakis, L., Kassar, M., Sasaki, C., et al. (2004). Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: Long-term follow-up. Journal of Clinical Oncology, 22, 3061–3069.

    Article  CAS  PubMed  Google Scholar 

  12. Woolgar, J. A., Rogers, S. N., Lowe, D., Brown, J. S., & Vaughan, E. D. (2003). Cervical lymph node metastasis in oral cancer: The importance of even microscopic extracapsular spread. Oral Oncology, 39, 130–137.

    Article  CAS  PubMed  Google Scholar 

  13. Takes, R. P. (2004). Staging of the neck in patients with head and neck squamous cell cancer: Imaging techniques and biomarkers. Oral Oncology, 40, 656–667.

    Article  PubMed  Google Scholar 

  14. Basu, S., Khanra, M., Dash, B., Majumdar, J., Biswas, J., & Chaudhuri, P. (1999). The role of neoadjuvant and adjuvant chemotherapy regimens consisting of different combinations of drugs in the treatment of advanced oral cancer. Medical Oncology, 16, 199–203.

    Article  CAS  PubMed  Google Scholar 

  15. Benasso, M., Lionetto, R., Corvo, R., Ponzanelli, A., Vitale, V., & Rosso, R. (2003). Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation. European Journal of Cancer, 39, 1895–1898.

    Article  CAS  PubMed  Google Scholar 

  16. Beckmann, G. K., Hoppe, F., Pfreundner, & Flentje, M. P. (2005). Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head & Neck, 27, 36–43.

    Article  Google Scholar 

  17. Olasz, L., Szabó, I., & Horvath, A. (1988). A combined treatment for advanced oral cavity cancers. Cancer, 62, 1267–1274.

    Article  CAS  PubMed  Google Scholar 

  18. Olasz, L., Kwashie, F., Herczegh, P., Bruncsics, Z., Horváth, A., & Királyfalvi, L. (1996). A comparative study of preoperative B-V-M-M chemotherapy and irradiation in advanced squamous cell cancer of the oral cavity. Neoplasma, 43, 51–56.

    CAS  PubMed  Google Scholar 

  19. Woolgar, J. A., Rogers, S., West, C. R., Errington, R. D., Brown, J. S., & Vaughan, E. D. (1999). Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncology, 35, 257–265.

    Article  CAS  PubMed  Google Scholar 

  20. Licitra, L., Grandi, C., Guzzo, M., Mariani, L., Lo Vullo, S., Valvo, F., et al. (2003). Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial. Journal of Clinical Oncology, 21, 327–333.

    Article  CAS  PubMed  Google Scholar 

  21. Posner, M. R., Glisson, B., Frenette, G., Al-Sarraf, M., Colevas, A. D., Norris, C. M., et al. (2001). Multicenter phase I–II trial of docetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. Journal of Clinical Oncology, 19, 1096–1104.

    CAS  PubMed  Google Scholar 

  22. Sutton, D. N., Brown, J. S., Rogers, S. N., Vaughan, E. D., & Woolgar, J. A. (2003). The prognostic implications of the surgical margin in oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery, 32, 30–34.

    Article  CAS  PubMed  Google Scholar 

  23. Jacobs, J. R., Ahmad, K., Casiano, R., Schuller, D. E., Scott, C., Laramore, G. E., et al. (1993). Implications of positive surgical margins. The Laryngoscope, 103, 64–68.

    Article  CAS  PubMed  Google Scholar 

  24. Maipang, T., Maipang, M., Geater, A., Panjapiyakul, C., Watanaarepornchai, S., & Punperk, S. (1995). Combination chemotherapy as induction therapy for advanced resectable head and neck cancer. Journal of Surgical Oncology, 59, 80–85.

    Article  CAS  PubMed  Google Scholar 

  25. Rapidis, A. D., Trichas, M., Stavrinidis, E., Roupakia, A., Ioannidou, G., Kritselis, G., et al. (2006). Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: Final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a 4-year follow up. Oral Oncology, 42, 675–684.

    Article  CAS  PubMed  Google Scholar 

  26. Greene, F. L., & Page, D. L. (2002). AJCC cancer staging manual (6th ed., pp. 17–25). New York, NY: Springer.

    Google Scholar 

Download references

Acknowledgement

We would like to thank Professor Gábor Rébék-Nagy for the English language revision of this manuscript.

Conflict of interest and funding source

All authors state that there are no financial interests or commercial associations that may create a conflict of interest with information presented in this manuscript. There is no involvement of any study sponsors.

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, University of Pécs, 5. Dischka Street, Pécs, 7622, Hungary

    Lajos Olasz, Enikő Orsi & József Szalma

  2. Department of Informatics, University of Pécs, 12. Szigeti Street, Pécs, 7624, Hungary

    Tamás Markó

Authors
  1. Lajos Olasz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enikő Orsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tamás Markó
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. József Szalma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lajos Olasz.

Additional information

This study was partially presented as lectures IX, International Danubius Congress, and XII, Congress of the Hungarian Association of Oral and Maxillofacial Surgery, October 16–18, 2008, Budapest, Hungary, as an invited presenter; and EHRLICH II—2nd World Conference on Magic Bullets Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich, Nürnberg, Germany, October 3–5, 2008, also as an invited presenter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olasz, L., Orsi, E., Markó, T. et al. Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC). Cancer Metastasis Rev 29, 607–611 (2010). https://doi.org/10.1007/s10555-010-9259-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-010-9259-7

Keywords

Search

Navigation